Forward Management’s Edwards Lifesciences EW Stock Holding History

Forward Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-164,094	Closed	-$2.73M	–	277
2015 Q2	$2.73M	Sell	164,094 -32,136	-16%	-$725K	0.17%	88
2015 Q1	$3.15M	Buy	196,230 +31,500	+19%	+$707K	0.19%	79
2014 Q4	$2.48M	Buy	164,730 +7,800	+5%	+$157K	0.14%	102
2014 Q3	$1.86M	Sell	156,930 -135,450	-46%	-$2.14M	0.11%	115
2014 Q2	$3.65M	Sell	292,380 -26,820	-8%	-$364K	0.21%	67
2014 Q1	$3.84M	Buy	+319,200	New	+$3.68M	0.22%	65

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return

Forward Management's EW Position: Q3 2015 in Review

Forward Management sold out of Edwards Lifesciences (EW) in Q3 2015, closing a stake of 164,094 shares — an estimated $2.73M sold.

Forward Management first reported a position in EW in Q1 2014 and held it in 6 quarters. The position peaked at $3.84M in Q1 2014. 569 funds tracked by Wall St. Rank hold EW as of Q3 2015.

Forward Management reported no remaining Edwards Lifesciences position as of Q3 2015 after selling out during the quarter.
Forward Management sold 164,094 Edwards Lifesciences shares in Q3 2015, an estimated $2.73M.
Forward Management first reported a position in Edwards Lifesciences in Q1 2014 and held it in 6 quarters.
Forward Management's Edwards Lifesciences position peaked at $3.84M in Q1 2014.
569 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2015.

Based on Forward Management's 13F filing for Q3 2015, filed 9 Nov 2015.